Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that it has priced an underwritten offering (the “offering”) in aggregate principal amount of $25 billion in senior notes (the “notes”). The offering is expected to close on March 13, 2026, subject to the satisfaction of customary closing conditions. Salesforce intends to use all of the net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by Sa...

LYON, Francia--(BUSINESS WIRE)--Eurofins Biomnis, proveedor europeo líder en servicios especializados de diagnóstico clínico y parte de la red internacional de laboratorios Eurofins, anuncia el desarrollo y la validación satisfactorios de un nuevo método de cromatografía líquida acoplada a espectrometría de masas en tándem (LC-MS/MS) para la detección y cuantificación de la toxina cereulida en muestras de heces humanas. Esta innovación destaca la innovación diagnóstica de Eurofins Biomnis y su...

LYON, Frankreich--(BUSINESS WIRE)--Eurofins Biomnis, ein führender europäischer Anbieter von spezialisierten klinischen Diagnostikdienstleistungen, der zum globalen Netzwerk der Eurofins-Labore gehört, kündigt die erfolgreiche Entwicklung und Validierung einer neuen Flüssigchromatographie-Tandem-Massenspektrometrie-Methode (Liquid Chromatography Tandem Mass Spectrometry, LC-MS/MS) zum Nachweis und zur Quantifizierung von Cereulid-Toxin in menschlichen Stuhlproben an. Diese Innovation unterstrei...

LIONE, Francia--(BUSINESS WIRE)--Eurofins Biomnis, azienda europea leader nella fornitura di servizi specializzati di diagnostica clinica e parte della rete globale di laboratori Eurofins, annuncia il successo dello sviluppo e della convalida di un nuovo metodo di spettrometria di massa tandem e cromatografia liquida (LC‑MS/MS) per il rilevamento e la quantificazione della tossina cereulide in campioni fecali umani. Questa innovazione sottolinea la novità diagnostica di Eurofins Biomnis, nonché...

LYON, Frankrijk--(BUSINESS WIRE)--Eurofins Biomnis, een toonaangevende Europese aanbieder van gespecialiseerde klinische diagnostische diensten en onderdeel van het wereldwijde netwerk van Eurofins-laboratoria, kondigt de succesvolle ontwikkeling en validatie aan van een nieuwe vloeistofchromatografie-tandem massaspectrometrie (LC-MS/MS)-methode voor de detectie en kwantificering van cereulidetoxine in menselijke ontlastingmonsters. Deze innovatie onderstreept de diagnostische innovatie van Eur...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Trip.com Group Limited (NASDAQ: TCOM) between April 30, 2024 and January 13, 2026, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Trip.com investors under the federal securities laws. To join the Trip.com class action, go to https://rosenlegal.com/submit-form/?case_id=50668 or call Phillip Ki...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Trip.com Group Limited (NASDAQ: TCOM) American Depository Shares ("ADS") between April 30, 2025 and January 13, 2026. Trip.com claims to be a leading global one-stop travel service provider, integrating a comprehensive suite of travel products and services and differentiated travel content. For more information, submit a form, email at...

NEW YORK--(BUSINESS WIRE)--CI&T (NYSE: CINT, “Company”), a global partner in tech-integrated business solutions, announces today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (SEC). The report is available on the SEC's website, at http://www.sec.gov, and on CI&T's website, at https://investors.ciandt.com/ (under Financials > SEC Filings). Shareholders may receive a hard copy of CI&T's...

SHANGHAI--(BUSINESS WIRE)--Haleon, un'azienda di consumo concentrata unicamente sul miglioramento della salute quotidiana, sta investendo 65 milioni di sterline in un nuovo impianto di produzione all'avanguardia di prodotti per l'igiene orale a Shanghai. La struttura supporterà l'espansione del suo portafoglio di prodotti per l'igiene orale, che comprende i marchi globali Sensodyne e parodontax, nelle città cinesi di livello 2 e 3 in rapida crescita, dove i redditi in aumento, una maggiore cons...

NEW YORK--(BUSINESS WIRE)--Accenture and Google Cloud will help organizations strengthen cloud security....